HugoScore hugoscore.org

Clinical decision support

OpenEvidence

OpenEvidence’s historical profile describes clinician-controlled evidence and Visits workflows. Current official pages could not be retrieved in the September reassessment. The historical score is preserved provisionally, without treating the failed retrieval as a fresh confirmation or an agency penalty.

Current verification incomplete Read full report Open directory

Current verification incomplete. The September 8 assessment records access limitations. The earlier 2026-06-10 evidence has not been freshly confirmed.

18 /100 toward patient-directed
Agency posture Institution-directed, patient-affecting
The question we ask Who does OpenEvidence serve in this deployment?
Control Clinician evidence and Visits workflows described in the June baseline. Current public verification was blocked.
Agency read Institution-directed, patient-affecting
Vendor
OpenEvidence Inc.
Who it serves
Institutional, clinician-only, patient-affecting
Primary User
Physicians, other healthcare professionals, and health systems
Control Model
Vendor-hosted public service. Controls and downstream processors depend on the assessed deployment.
Patient Impact
Historical source-grounded answers may strengthen clinician reasoning and patient materials. Whether patients receive inspectable sources or can challenge the generated context remains unverified.
Profile Status
Current verification incomplete
Last assessed
Sep 8, 2026
Review Confidence
Low for present deployment, moderate for the frozen historical scope (AI-assisted draft)
AI / Model
OpenAI Codex / GPT-6
Human Review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Summary judgment · 18 out of 100 toward patient-directed

Clinician evidence and Visits workflows described in the June baseline. Current public verification was blocked.

Institution-directed, patient-affecting

OpenEvidence’s historical profile describes clinician-controlled evidence and Visits workflows. Current official pages could not be retrieved in the September reassessment. The historical score is preserved provisionally, without treating the failed retrieval as a fresh confirmation or an agency penalty.

Patient agency

How this tool changes agency

Expands agency when

Historical source-grounded answers may strengthen clinician reasoning and patient materials. Whether patients receive inspectable sources or can challenge the generated context remains unverified.

Limits agency when

All current patient-facing controls and policy changes remain unverified after the bounded access failures

Patient agency assessment

Who sets and changes the goal?

Patient authority

The historical deployment places the clinician in control of questions, context and outputs. Nothing newly recovered establishes direct patient control, but blocked access cannot establish its absence.

What can the patient understand, question, or do?

Critical capacity

Historical source-grounded answers may strengthen clinician reasoning and patient materials. Whether patients receive inspectable sources or can challenge the generated context remains unverified.

Can the patient evaluate the conditions of use?

Informed control

Advertising separation, patient notice, refusal and correction need deployment evidence. Previously stated privacy protections must retain their June provenance.

Text findings

Conditions of use

Published controls and their limits

Advertising separation, patient notice, refusal and correction need deployment evidence. Previously stated privacy protections must retain their June provenance.

What remains unknown?

Not tested or not established

All current patient-facing controls and policy changes remain unverified after the bounded access failures

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

All current patient-facing controls and policy changes remain unverified after the bounded access failures No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

Current verification incomplete · Low for present deployment, moderate for the frozen historical scope (AI-assisted draft)